COVID-19 Clinical Trials in Los Angeles

Showing 121-140 of 168 trials

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

NCT05258617

An informational evaluation of COVID-19 patients who receive low-level laser therapy in addition to a normal regimen of treatment for symptoms associate with COVID-19. Results are compared to statistical observations published in literature from patients receiving standard care for COVID-19 symptoms without low-level laser therapy.

COVID-19Acute Respiratory Distress Syndrome

Ward Photonics LLC5 participantsStarted Feb 2022

Berkeley, California, United States • Los Angeles, California, United States • Santa Monica, California, United States +4 more locations

TERMINATEDPhase 2< 1 mile

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

NCT04565249

Evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with acute respiratory distress syndrome (ARDS) associated with at least severe COVID-19

Acute Respiratory Distress SyndromeSARS-CoV-2

Pliant Therapeutics, Inc.6 participantsStarted Oct 2020

Phoenix, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +3 more locations

COMPLETEDPhase 2< 1 mile

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

NCT04363736

This study will assess the pharmacodynamics, pharmacokinetics, safety and efficacy of two different doses of tocilizumab (TCZ) in combination with standard-of-care (SOC) in hospitalized adult participants with moderate to severe COVID-19 pneumonia.

COVID-19 Pneumonia

Hoffmann-La Roche97 participantsStarted May 2020

Phoenix, Arizona, United States • Fullerton, California, United States • Los Angeles, California, United States +21 more locations

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

COVID-19 Trials in Other Cities

Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake

Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Adaptive COVID-19 Treatment Trial (ACTT)

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

COVID-19 and Venous Thromboembolism Risk

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19

A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

A Study of Immune Responses to the Virus That Causes COVID-19

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Treatment for COVID-19 in High-Risk Adult Outpatients

Other Conditions in Los Angeles